papaverine has been researched along with prednisone in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Almici, C; Lazzaroni, G | 1 |
RITTER, U | 1 |
Ben-David, J; Fradis, M; Luntz, M; Magamsa, I; Podoshin, L; Sabo, E | 1 |
1 review(s) available for papaverine and prednisone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 other study(ies) available for papaverine and prednisone
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
[Drug therapy of acute cerebral ischemia. Clinical study].
Topics: Brain; Dextrans; Dihydroergotoxine; Ergoloid Mesylates; Humans; Intracranial Arteriosclerosis; Intracranial Embolism and Thrombosis; Ischemia; Lidocaine; Papaverine; Prednisone | 1974 |
[DIAGNOSIS AND TREATMENT OF PANCREATITIS].
Topics: Amylases; Anti-Bacterial Agents; Antibiotics, Antitubercular; Atropine; Chyle; Clinical Enzyme Tests; Dermatologic Agents; Diagnosis; Humans; Hypertension; Norepinephrine; Pancreatitis; Papaverine; Prednisolone; Prednisone; Strophanthins | 1963 |
Tinnitus as a prognostic sign in idiopathic sudden sensorineural hearing loss.
Topics: Adult; Aged; Audiometry; Auditory Threshold; Dextrans; Female; Glucocorticoids; Hearing Loss, Sudden; Humans; Male; Middle Aged; Papaverine; Plasma Substitutes; Prednisone; Prognosis; Prospective Studies; Risk Factors; Time Factors; Tinnitus; Vasodilator Agents | 2001 |